Qingmu passed cGMP site inspection from USFDA
In the afternoon of September 15th, 2021, along with closed meeting of cGMP site inspection, Qingmu passed this site inspection from USFDA successfully.
This inspection was postponed several times due to COVID-19, and we never expect this inspection will be performed so soon. We got the notification from USFDA officer on August 26th that the site inspection will be performed from September 1~7, and after five days inspection, the officer gave a high evaluation to the compliance of Qingmu’s cGMP system.
It’s the first GMP inspection for Qingmu from US and EU Authorities, providing a new opportunity for Qingmu to further expand API business in US market, and also the global market. This is an important milestone in Qingmu’s internationalization strategy, with important practical significance and strategic value!
